UroCor
This article was originally published in The Gray Sheet
Executive Summary
NRC clearance to market ProstaSeed I-125 seeds is announced Jan. 11, following 510(k) approval in April. UroCor will cooperate in a nationwide product launch with Mallinckrodt, which will distribute ProstaSeed through its 35 nuclear medicine and 80 independent pharmacies as well as through group purchasing contracts with hospital groups like Premier. Tampa-based Prostate Services of America will distribute the seeds to hospitals and physician practices specializing in treating prostate cancer, according to the company
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.